Augustina Isioma Ikusemoro: Transfusion Should Be Based on Clinical Need, Not Just Numbers
Augustina Isioma Ikusemoro, Hematology and Transfusion Medicine Specialist at Sharjah Blood Transfusion and Research Center, shared a post on LinkedIn:
“Transfuse the patient – not the number
A laboratory value alone should never be the reason a patient receives blood.
Blood transfusion is a powerful, life-saving therapy – but it is not risk – free, and it is not routine care.
Every unit transfused must answer one critical question:
Does this patient truly need it right now?
Clinical transfusion decisions should always consider:
- Symptoms of inadequate oxygen delivery
- Ongoing or active bleeding
- Cardiovascular risk status
- Acute clinical conditions (ACS, stroke, major surgery)
- Physiological reserve and comorbidities
- Hemoglobin thresholds in stable/hospitalized patients ( less than seven grams per deciliter)
Because unnecessary transfusions expose patients to real risks:
- Transfusion reactions
- Trali
- Taco
- Immunomodulation
- Iron overload
- Residual infection risk
- Loss of scarce blood resources for those in urgent need
Good transfusion practice is not about correcting numbers.
It is about protecting patients.
Safe transfusion starts with:
- The right patient
- The right indication
- The right timing
Better outcomes happen when transfusion decisions are clinically justified, evidence-guided, and patient-centered.
Signature of Blood Doki
- Educate.
- Empower.
- Elevate.”
Other posts featuring Augustina Isioma Ikusemoro on Hemostasis Today.
-
May 6, 2026, 12:12Mona Ranade: Insights from a Medeloop Analytics Study Evaluate Catheter-Directed Therapy in Pulmonary Embolism
-
May 6, 2026, 11:50Natalie L. Baggio: A 24/7 Neurointerventional Stroke Care at Corewell Health Is Now a Reality
-
May 6, 2026, 11:30Paula Caporal: Consensus on the Diagnosis and Management of Pediatric Stroke in Argentina
-
May 6, 2026, 11:14Li Khim Kwah: Proud for the Development of The New Singapore Stroke Rehabilitation Guideline
-
May 6, 2026, 10:55Hugo Antonio Romo Rubio: A New Paradigm in Treatment for Hemophilia A from FRONTIERS2 Phase 3 Study
-
May 6, 2026, 10:40Ifeanyichukwu Ifechidere: Why INR Can Be Dangerously Misleading
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Connecting with so Many Families and Advocates at HFA 2026
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?